Apr 19 |
New Strong Sell Stocks for April 19th
|
Apr 18 |
Bio-Rad Laboratories (BIO) to Post Q1 Earnings: What Awaits?
|
Apr 18 |
Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
|
Apr 17 |
Bio-Rad Laboratories (NYSE:BIO shareholders incur further losses as stock declines 14% this week, taking three-year losses to 53%
|
Apr 16 |
Bio-Rad (BIO) Hurt by Softness in BioPharma and Competition
|
Apr 14 |
Bio-Rad: A Lackluster Picks-And-Shovels Life Science Company With A Key Investment Kicker
|
Apr 13 |
OncoCyte Corp (OCX) Q4 2023 Earnings Call Transcript Highlights: Strategic Partnerships and ...
|
Apr 13 |
Q4 2023 OncoCyte Corp Earnings Call
|
Apr 11 |
Oncocyte stock rallies 90% post-market on Bio-Rad partnership
|
Apr 11 |
Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay
|